Update: 21.03.2023
Last week: 10 week 2023 (06.02.2023 - 12.03.2023)
Last full month: February 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 104 310 | -0.3% | 3.0% | 0.3 | 27 218 182 | -1.5% | 3.5% | 0.3 | -10.2% |
| MoM | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| YTD | 1 089 982 | -68.9% | 2.8% | -3.3 | 293 778 262 | -56.7% | 3.4% | -2.4 | -32.6% |
| MAT | 7 429 134 | -50.5% | 4.0% | -2.6 | 1 635 443 564 | -38.7% | 4.1% | -2 | -17.9% |
| DEXALGIN | |||||||||
| WoW | 15 223 | -4.9% | 0.3% | 0 | 8 065 358 | -7.2% | 1.1% | 0 | -4.7% |
| MoM | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| YTD | 169 824 | -65.4% | 0.4% | -0.4 | 91 306 067 | -53.3% | 1.2% | -0.9 | -25.5% |
| MAT | 1 264 318 | -36.4% | 0.5% | -0.2 | 582 333 516 | -24.1% | 1.5% | -0.5 | -11.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 52 377 | -4.5% | 42.1% | 3.2 | 33 144 512 | -4.7% | 51.3% | 2.9 | -11.8% |
| MoM | 202 093 | -11.2% | 38.5% | -1 | 128 123 690 | -13.1% | 48.2% | -2.3 | -8.8% |
| YTD | 513 658 | -59.0% | 39.3% | -21.4 | 329 036 077 | -46.1% | 49.5% | -17.4 | -36.7% |
| MAT | 3 544 340 | -35.3% | 48.6% | -15.4 | 1 927 142 734 | -25.1% | 55.1% | -14.1 | -14.8% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 497 | -3.7% | 28.7% | 0.3 | 15 897 129 | -3.6% | 45.1% | 0.2 | -4.7% |
| MoM | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| YTD | 202 958 | -44.2% | 29.3% | -10.4 | 158 388 062 | -26.6% | 46.4% | -7.8 | -24.4% |
| MAT | 1 265 523 | -24.1% | 34.8% | -6 | 848 062 394 | -13.6% | 48.7% | -6.6 | -11.0% |
| FASTUM | |||||||||
| WoW | 13 863 | -4.9% | 0.8% | 0 | 8 348 757 | -4.9% | 2.2% | 0 | -6.3% |
| MoM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| YTD | 143 646 | -51.0% | 0.9% | -0.6 | 87 621 008 | -38.0% | 2.4% | -0.7 | -19.0% |
| MAT | 890 785 | -35.4% | 1.0% | -0.4 | 492 666 271 | -23.7% | 2.3% | -0.7 | -5.7% |
| IODOMARIN | |||||||||
| WoW | 68 558 | -7.8% | 22.8% | 0.3 | 12 869 800 | -7.9% | 9.3% | 0 | -9.0% |
| MoM | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| YTD | 634 488 | -20.4% | 21.8% | 0.4 | 118 416 838 | -22.1% | 8.6% | -0.6 | -21.9% |
| MAT | 3 131 235 | -8.3% | 20.6% | -0.7 | 606 453 504 | -5.4% | 8.9% | -0.6 | -5.3% |
| LIOTON | |||||||||
| WoW | 15 114 | -1.4% | 1.6% | 0 | 19 149 212 | -2.4% | 4.0% | 0 | -3.4% |
| MoM | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.6% |
| YTD | 149 097 | -55.1% | 1.7% | -1 | 186 719 269 | -39.8% | 4.3% | -1 | -27.8% |
| MAT | 1 068 774 | -38.8% | 2.0% | -0.8 | 1 184 044 955 | -20.7% | 4.4% | -1.3 | -14.5% |
| MEZYM | |||||||||
| WoW | 214 916 | 1.7% | 19.7% | 0.7 | 33 836 370 | 0.9% | 13.4% | 0.6 | -1.7% |
| MoM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| YTD | 2 127 478 | -60.2% | 19.4% | -11.6 | 333 480 921 | -58.2% | 13.2% | -9.2 | -36.4% |
| MAT | 14 134 789 | -36.2% | 22.8% | -7.2 | 2 180 129 343 | -31.0% | 16.1% | -6.1 | -16.2% |
| MIG 400 | |||||||||
| WoW | 109 969 | -1.6% | 2.4% | 0.1 | 12 845 134 | 1.2% | 1.7% | 0.1 | -4.7% |
| MoM | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| YTD | 1 055 829 | -49.5% | 2.2% | -1.1 | 129 003 131 | -46.8% | 1.7% | -0.9 | -25.5% |
| MAT | 7 360 513 | -29.9% | 3.0% | -0.8 | 880 839 257 | -26.0% | 2.3% | -0.8 | -11.3% |
| PROSTAMOL | |||||||||
| WoW | 20 640 | -5.4% | 13.0% | 0.3 | 30 895 072 | -6.3% | 14.6% | 0.3 | -7.5% |
| MoM | 80 544 | -12.7% | 12.9% | -0.9 | 122 384 313 | -11.5% | 14.6% | -1 | -6.3% |
| YTD | 205 938 | -57.2% | 13.3% | -9.7 | 310 709 642 | -52.7% | 15.0% | -9.5 | -26.1% |
| MAT | 1 270 923 | -41.2% | 16.0% | -8.3 | 1 819 169 760 | -34.8% | 17.1% | -8.9 | -10.7% |
| RESPERO MYRTOL | |||||||||
| WoW | 21 370 | -12.2% | 6.8% | -0.1 | 12 154 898 | -12.9% | 8.0% | -0.2 | -11.4% |
| MoM | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
| YTD | 232 008 | -43.7% | 7.1% | -3.1 | 133 172 118 | -28.2% | 8.3% | -1.6 | -18.8% |
| MAT | 1 121 140 | 1.4% | 7.6% | 0.5 | 571 269 793 | 13.3% | 8.1% | 0.9 | -4.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 1 089 982 | -68.9% | 2.8% | -3.3 | 293 778 262 | -56.7% | 3.4% | -2.4 | -32.6% |
| DEXALGIN | 169 824 | -65.4% | 0.4% | -0.4 | 91 306 067 | -53.3% | 1.2% | -0.9 | -25.5% |
| ESPUMISAN (ADULTS) | 513 658 | -59.0% | 39.3% | -21.4 | 329 036 077 | -46.1% | 49.5% | -17.4 | -36.7% |
| ESPUMISAN BABY | 202 958 | -44.2% | 29.3% | -10.4 | 158 388 062 | -26.6% | 46.4% | -7.8 | -24.4% |
| FASTUM | 143 646 | -51.0% | 0.9% | -0.6 | 87 621 008 | -38.0% | 2.4% | -0.7 | -19.0% |
| IODOMARIN | 634 488 | -20.4% | 21.8% | 0.4 | 118 416 838 | -22.1% | 8.6% | -0.6 | -21.9% |
| LIOTON | 149 097 | -55.1% | 1.7% | -1 | 186 719 269 | -39.8% | 4.3% | -1 | -27.8% |
| MEZYM | 2 127 478 | -60.2% | 19.4% | -11.6 | 333 480 921 | -58.2% | 13.2% | -9.2 | -36.4% |
| MIG 400 | 1 055 829 | -49.5% | 2.2% | -1.1 | 129 003 131 | -46.8% | 1.7% | -0.9 | -25.5% |
| PROSTAMOL | 205 938 | -57.2% | 13.3% | -9.7 | 310 709 642 | -52.7% | 15.0% | -9.5 | -26.1% |
| RESPERO MYRTOL | 232 008 | -43.7% | 7.1% | -3.1 | 133 172 118 | -28.2% | 8.3% | -1.6 | -18.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 429 134 | -50.5% | 4.0% | -2.6 | 1 635 443 564 | -38.7% | 4.1% | -2 | -17.9% |
| DEXALGIN | 1 264 318 | -36.4% | 0.5% | -0.2 | 582 333 516 | -24.1% | 1.5% | -0.5 | -11.3% |
| ESPUMISAN (ADULTS) | 3 544 340 | -35.3% | 48.6% | -15.4 | 1 927 142 734 | -25.1% | 55.1% | -14.1 | -14.8% |
| ESPUMISAN BABY | 1 265 523 | -24.1% | 34.8% | -6 | 848 062 394 | -13.6% | 48.7% | -6.6 | -11.0% |
| FASTUM | 890 785 | -35.4% | 1.0% | -0.4 | 492 666 271 | -23.7% | 2.3% | -0.7 | -5.7% |
| IODOMARIN | 3 131 235 | -8.3% | 20.6% | -0.7 | 606 453 504 | -5.4% | 8.9% | -0.6 | -5.3% |
| LIOTON | 1 068 774 | -38.8% | 2.0% | -0.8 | 1 184 044 955 | -20.7% | 4.4% | -1.3 | -14.5% |
| MEZYM | 14 134 789 | -36.2% | 22.8% | -7.2 | 2 180 129 343 | -31.0% | 16.1% | -6.1 | -16.2% |
| MIG 400 | 7 360 513 | -29.9% | 3.0% | -0.8 | 880 839 257 | -26.0% | 2.3% | -0.8 | -11.3% |
| PROSTAMOL | 1 270 923 | -41.2% | 16.0% | -8.3 | 1 819 169 760 | -34.8% | 17.1% | -8.9 | -10.7% |
| RESPERO MYRTOL | 1 121 140 | 1.4% | 7.6% | 0.5 | 571 269 793 | 13.3% | 8.1% | 0.9 | -4.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 104 310 | -0.3% | 3.0% | 0.3 | 27 218 182 | -1.5% | 3.5% | 0.3 | -10.2% |
| DEXALGIN | 15 223 | -4.9% | 0.3% | 0 | 8 065 358 | -7.2% | 1.1% | 0 | -4.7% |
| ESPUMISAN (ADULTS) | 52 377 | -4.5% | 42.1% | 3.2 | 33 144 512 | -4.7% | 51.3% | 2.9 | -11.8% |
| ESPUMISAN BABY | 20 497 | -3.7% | 28.7% | 0.3 | 15 897 129 | -3.6% | 45.1% | 0.2 | -4.7% |
| FASTUM | 13 863 | -4.9% | 0.8% | 0 | 8 348 757 | -4.9% | 2.2% | 0 | -6.3% |
| IODOMARIN | 68 558 | -7.8% | 22.8% | 0.3 | 12 869 800 | -7.9% | 9.3% | 0 | -9.0% |
| LIOTON | 15 114 | -1.4% | 1.6% | 0 | 19 149 212 | -2.4% | 4.0% | 0 | -3.4% |
| MEZYM | 214 916 | 1.7% | 19.7% | 0.7 | 33 836 370 | 0.9% | 13.4% | 0.6 | -1.7% |
| MIG 400 | 109 969 | -1.6% | 2.4% | 0.1 | 12 845 134 | 1.2% | 1.7% | 0.1 | -4.7% |
| PROSTAMOL | 20 640 | -5.4% | 13.0% | 0.3 | 30 895 072 | -6.3% | 14.6% | 0.3 | -7.5% |
| RESPERO MYRTOL | 21 370 | -12.2% | 6.8% | -0.1 | 12 154 898 | -12.9% | 8.0% | -0.2 | -11.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| DEXALGIN | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| ESPUMISAN (ADULTS) | 202 093 | -11.2% | 38.5% | -1 | 128 123 690 | -13.1% | 48.2% | -2.3 | -8.8% |
| ESPUMISAN BABY | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| FASTUM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| IODOMARIN | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| LIOTON | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.6% |
| MEZYM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| MIG 400 | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| PROSTAMOL | 80 544 | -12.7% | 12.9% | -0.9 | 122 384 313 | -11.5% | 14.6% | -1 | -6.3% |
| RESPERO MYRTOL | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs